Los Angeles S&T Newsletter #34 - January 2013

, Share

A new year always comes with resolutions to travel abroad or to broaden our horizons to new experiences. In this spirit, we would like to take this opportunity to continue to encourage scientific cooperation between France and the United States through the Chateaubriand Scholarship for science, technology, engineering and mathematics (STEM). Open to PhD students currently registered in American universities, the scholarship is offered by the Office of Science and Technology of the Embassy of France in the United States and gives students the opportunity to travel and spend four to nine months conducting research in a French laboratory. Recipients will receive a monthly allowance, travel support and health insurance during their time abroad. All students of STEM and health disciplines should consider applying by the February 1 deadline. More information can be found at http://stem.chateaubriand-fellowship.org/.

In addition, we’d like to take a moment to wish everyone a happy, healthy and safe New Year.

Kara Leary, Science and Technology Intern
Aurelie Perthuison, Deputy Attaché for Science and Technology
Fabien Agenes, Attaché for Science and Technology

To read the full version of the January 2013 newsletter, please scroll down or click here. You can also register here to receive emails about events organized by the OST LA.




December 3, 2012: Water, climate change project gives new life to Biosphere 2

The massive greenhouse that once fed researchers who lived in the sealed-off world of Biosphere 2 is getting new life as a grand experiment to unlock the secrets of Earth’s water cycle. The University of Arizona last week commissioned the Landscape Evolution Observatory. The $7.5 million project under a half-acre of glass includes three identical “watersheds” sculpted from ground volcanic rock and loaded with thousands of subsurface sensors. Its builders consider it one of a kind because the structure’s near-total containment will allow for tracking every drop of water through intentional changes in the enclosed environment. The results could help them understand how climate change may affect the Sonoran Desert or the Colorado River Basin as well as more basic questions such as how plant and microbial life alter Earth’s natural systems.

To access the full article:

December 3, 2012: Women with sleep apnea have higher degree of brain damage than men, UCLA study shows

Women suffering from sleep apnea have, on the whole, a higher degree of brain damage than men with the disorder, according to a first-of-its-kind study conducted by researchers at the UCLA School of Nursing. The findings are reported in the December issue of the peer-reviewed journal SLEEP. Obstructive sleep apnea is a serious disorder that occurs when a person’s breathing is repeatedly interrupted during sleep, sometimes hundreds of times. Each time, the oxygen level in the blood drops, eventually resulting in damage to many cells in the body. If left untreated, it can lead to high blood pressure, stroke, heart failure, diabetes, depression and other serious health problems.

To access the full article:

December 3, 2012: Salk scientists develop faster, safer method for producing stem cells

A new method for generating stem cells from mature cells promises to boost stem cell production in the laboratory, helping to remove a barrier to regenerative medicine therapies that would replace damaged or unhealthy body tissues. The technique, developed by researchers at the Salk Institute for Biological Studies, allows for the unlimited production of stem cells and their derivatives as well as reduces production time by more than half, from nearly two months to two weeks.

To access the full article:

December 4, 2012: Baby’s health tied to a mother’s value for family

The value that an expectant mother places on family — regardless of the reality of her own family situation — predicts the birth weight of her baby and whether the child will develop asthma symptoms three years later, according to new research from USC. The findings suggest that one’s culture is a resource that can provide tangible physical health benefits. “We know that social support has profound health implications. Yet, in this case, this is more a story of beliefs than of actual family support,” said Cleopatra Abdou, assistant professor at the USC Davis School of Gerontology.

To access the full article:

December 4, 2012: USC Norris cancer research ranks among top clinical advances

Research from the USC Norris Comprehensive Cancer Center that identifies specific genes that need to be turned off in order for cancer cells to survive was named one of the top 20 major advances in cancer research this year by the American Society of Clinical Oncology (ASCO). The study, “DNA methylation screening identifies driver epigenetic events of cancer cell survival,” first appeared in the May 15 issue of Cancer Cell, a peer-reviewed scientific journal. It is one of 87 studies highlighted in Clinical Cancer Advances 2012: ASCO’s Annual Report on Progress Against Cancer, available online in the Journal of Clinical Oncology.

To access the full article:

December 4, 2012: DELPHI Project Foretells Future of Personalized Population Health

Imagine a new type of healthcare app that does it all – it helps you understand your current health status, assists you in making changes in your life to improve your health, and takes into account the perspective of your entire life history, others in your age group—and perhaps even your neighborhood— who share similar characteristics. That’s the vision put forward by a team of physicians and computer scientists at the University of California, San Diego who are collaborating on a new digital resource that would take advantage of advances in databases, cyberinfrastructure and machine learning to usher in a new era of health and health care.

To access the full article:

December 5, 2012: Entomologist Named Distinguished Scientist of the Year

Entomologist Marshall Johnson, an extension specialist and researcher at the University of California, Riverside, has received the Distinguished Scientist of the Year Award from the International Organization for Biological Control — Nearctic Regional Section. Only one individual is recognized annually for the award. Nominees must have spent most of their career in the nearctic region, which encompasses the United States and Canada, and have made significant contributions to the area of biological control. Johnson has established an international reputation for outstanding contributions to the fields of biological control and entomology in research, teaching, extension, and administration.

To access the full article:

December 7, 2012: USC scientists discover new use for harmful greenhouse gas

A team of chemists at USC has developed a way to transform a hitherto useless ozone-destroying greenhouse gas that is the byproduct of Teflon manufacture into reagents for producing pharmaceuticals. The discovery was published in a paper titled “Taming of Fluoroform (CF3H): Direct Nucleophilic Trifluoromethylation of Si, B, S and C Centers” in the Dec. 7 issue of Science. The method is also being patented. Because of the popularity of Teflon — used on everything from cooking pans to armor-piercing bullets — there’s no shortage of its waste byproduct, fluoroform. Major chemical companies, such as DuPont, Arkema Inc. and others, have huge tanks of it and are unable to simply release it because of the potential damage to the environment. Fluoroform has an estimated global warming potential 11,700 times higher than carbon dioxide.

To access the full article:

December 7, 2012: Training the Next Generation of Heart Researchers

For more than four decades, the University of Arizona has played a pivotal role backed by the National Institutes of Health in training scientists to study what still is the leading cause of death in western countries – cardiovascular malfunctions and diseases.
“The goal of the grant is to train the next generation of scientists to have a broad view of cardiovascular research, to recognize the benefits of a multidisciplinary approach, and to project where cardiovascular research needs to be in 10, 15 or 20 years,” said Janis Burt, who is heading up the $2.6 million grant from the National Heart, Lung and Blood Institute.

To access the full article:

December 10, 2012: UCLA cancer scientists identify liposarcoma tumors that respond to chemotherapy

Liposarcoma, the most common type of sarcoma, is an often lethal form of cancer that develops in fat cells. It is particularly deadly, in part, because the tumors are not consistently visible with positron emission tomography (PET) scans that use a common probe called FDG and because they frequently do not respond to chemotherapy. Now, using a strategy that tracks cancer cells’ consumption of nucleosides, a team of researchers at UCLA’s Jonsson Comprehensive Center has identified a group of liposarcoma tumors that can be imaged by PET scanning using a tracer substance known as FAC. Furthermore, they have found that these tumors are sensitive to chemotherapy.

To access the full article:

December 10, 2012: UCI’s cloned redwoods rooted in research

UC Irvine’s redwoods sit like forlorn Christmas trees near the campus power plant and the Crawford Hall parking lot. They’re miniatures of Northern California’s ancient giants, a dwarf grove with drooping branches. But they’re still standing.
The trees began life with fanfare three decades ago. They are test-tube babies – samples of the world’s first artificially cloned Sequoia sempervirens created by now-deceased UCI biologist Ernest Ball. Manufactured from the straightest, mightiest redwoods, the seedlings enthralled the lumber industry and media alike in their early years.

To access the full article:

December 10, 2012: UCI radiology researcher to aid NASA bone density study

A UC Irvine researcher is part of a NASA effort to understand more about bone density loss during astronauts’ lengthy stays aboard the International Space Station. Joyce Keyak, professor in residence of radiological sciences, will employ a technique she created to analyze how microgravity-influenced changes to the hip bone might increase astronauts’ fracture risk during spaceflight, upon returning to Earth and with subsequent aging.

To access the full article:

December 12, 2012: How hepatitis C virus harms the liver

USC researchers have discovered a trigger by which the hepatitis C virus enters liver cells — shedding light on how the serious and potentially deadly virus can begin to damage the liver. The findings, reported in the Dec. 7 issue of The Journal of Biological Chemistry, may give scientists a target for future development of treatments for the virus. In the early stages of a hepatitis C virus (HCV) infection, the researchers found, the virus binds to receptors on the liver cells’ surface, activating PI3K and AKT, two proteins that control cell growth and metabolism, and which allow HCV to enter liver cells.

To access the full article:

December 13, 2012: UC Riverside Celebrates the School of Medicine Education Building

Community supporters, elected officials and administrators gathered Thursday, Dec. 13 to celebrate the second building affiliated with the UCR School of Medicine.
Visitors toured the School of Medicine Education Building that has been renovated and transformed with a medical simulation laboratory, a 100-seat lecture hall, 10 patient examination rooms and small group discussion rooms. It includes a wall in the entryway that has been dedicated to Dr. Thomas and Mrs. Salma Haider for their ongoing support for the School of Medicine.

To access the full article:

December 14, 2012: UCLA stem cell researchers receive more than $6 million in grants from state agency

Two cardiology investigators from the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at UCLA have been awarded grants totaling more than $6 million from the California Institute of Regenerative Medicine (CIRM), the state’s stem cell agency. The young physician–scientists, Dr. Reza Ardehali and Dr. Ali Nsair, will use the CIRM funds to conduct leading-edge research into the developmental and molecular biology of stem cells in their efforts to advance regenerative medicine for heart disease. Their studies will help form the foundation for translational and clinical advances, enabling human stem cellsnato be used for potential therapies and as tools for biomedical innovation.

To access the full article:

December 17, 2012: Toward a New Model of the Cell

Turning vast amounts of genomic data into meaningful information about the cell is the great challenge of bioinformatics, with major implications for human biology and medicine. Researchers at the University of California, San Diego School of Medicine and colleagues have proposed a new method that creates a computational model of the cell from large networks of gene and protein interactions, discovering how genes and proteins connect to form higher-level cellular machinery. The findings are published in the December 16 advance online publication of Nature Biotechnology.

To access the full article:

December 18, 2012: Woman Implanted With Invisible Hearing Aid at UAMC, First in Southwest

LoriAnn Harnish, 53, has suffered from hearing loss since having a high fever when she was 5 years old. The hearing impairment went undetected until the second grade, when her teacher spoke in a pitch she could not hear. Tests determined Harnish had 65 percent hearing loss in both ears. She used hearing aids, but never could hear well when using them, so learned to lip read. Today the Scottsdale resident is hearing more clearly than she has in decades after becoming the first person in the Southwest to receive a totally implantable hearing device at The University of Arizona Medical Center.

To access full article:

December 20, 2012: Genomic “Hotspots” Offer Clues to Causes of Autism, Other Disorders

An international team, led by researchers from the University of California, San Diego School of Medicine, has discovered that “random” mutations in the genome are not quite so random after all. Their study, to be published in the journal Cell on December 21, shows that the DNA sequence in some regions of the human genome is quite volatile and can mutate ten times more frequently than the rest of the genome. Genes that are linked to autism and a variety of other disorders have a particularly strong tendency to mutate. Clusters of mutations or “hotspots” are not unique to the autism genome but instead are an intrinsic characteristic of the human genome, according to principal investigator Jonathan Sebat, PhD, professor of psychiatry and cellular and molecule medicine, and chief of the Beyster Center for Molecular Genomics of Neuropsychiatric Diseases at UC San Diego.

To access the full article:

December 20, 2012: Chromosome "anchors" organize DNA during cell division

For humans to grow and to replace and heal damaged tissues, the body’s cells must continually reproduce, a process known as "cell division," by which one cell becomes two, two become four, and so on. A key question of biomedical research is how chromosomes, which are duplicated during cell division so that each daughter cell receives an exact copy of a person’s genome, are arranged during this process.
Now, scientists at the Salk Institute have discovered a new characteristic of human cell division that may help explain how our DNA is organized in the nucleus as cells reproduce. They found that telomeres, molecular caps that protect the ends of the chromosomes, move to the outer edge of the cell’s nucleus after they have been duplicated.

To access the full article:

December 21, 2012: Kindergartner undergoes very rare robotic surgery at UCLA

Leonidas Hill recently made history at Mattel Children’s Hospital UCLA, when the 5-year-old became the first pediatric patient in the western United States to undergo transoral robotic surgery (TORS) — a minimally invasive surgery performed with the help of a robot — to repair a rare congenital condition known as a laryngeal cleft. Mattel Children’s Hospital UCLA is one of only a handful of medical centers in the country offering this type of surgery, which is rarely done on pediatric patients. The technology allows surgeons to perform the operation through the mouth of the patient, rather than in the traditional manner, which requires external incisions and the splitting of the patient’s voice box.

To access the full article:

December 27, 2012: Strange behavior: new study exposes living cells to synthetic protein

One approach to understanding components in living organisms is to attempt to create them artificially, using principles of chemistry, engineering and genetics. A suite of powerful techniques – collectively referred to as synthetic biology – have been used to produce self-replicating molecules, artificial pathways in living systems and organisms bearing synthetic genomes.
In a new twist, John Chaput, a researcher at Arizona State University’s Biodesign Institute and colleagues at the Department of Pharmacology, Midwestern University, in Glendale, Ariz., have fabricated an artificial protein in the laboratory and examined the surprising ways living cells respond to it.

To access the full article:


December 3, 2012: Technique Selectively Represses Immune System

Researchers devised a way to successfully treat symptoms resembling multiple sclerosis in a mouse model. With further development, the technique might be used to treat multiple sclerosis and other autoimmune disorders. Multiple sclerosis is an autoimmune disease—a type of disease in which the immune system mistakenly attacks the body’s own tissues. In multiple sclerosis, immune system T cells attack myelin, the insulating material that encases nerve fibers. Resulting nerve damage in the brain and spinal cord can cause muscle weakness, loss of vision, numbness or tingling, and difficulty with coordination and balance. It can also lead to paralysis.

To access the full article:

December 4, 2012: NIH BrIDGs program helps overcome research roadblocks

Potential new treatments for a variety of cancers, spinal cord injury, and a rare disease that can lead to kidney failure are targets of a program that provides eligible scientists with no-cost access to National Institutes of Health therapeutic development contractor resources. Often, researchers apply to this NIH program, called Bridging Interventional Development Gaps (BrIDGs), because there is a lack of private resources or they have hit a roadblock and need additional expertise. Rather than funding successful applicants directly, BrIDGs enables NIH contractors to provide pre-clinical services — such as toxicology studies — for therapeutic projects that have demonstrated efficacy in a disease model.

To access the full article:

December 10, 2012: NIH scientists uncover how immune cells sense who they are

Scientists at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health, have demonstrated that DNA previously thought to be "junk" plays a critical role in immune system response. The team’s findings were published in Cell and may lead to the identification of new therapeutic targets for the treatment of immune-related disorders.
There are 3.2 billion DNA base pairs in the human genome, but only 2 percent are in the regions we call genes, which provide the code for proteins. Up until recently, the role of the rest of the genome was mostly unknown and overlooked. NIH researchers used whole genome DNA sequencing technology that allowed them to "see" which part of the genomic DNA is actively engaged in supporting various cellular functions.

To access the full article:

December 12, 2012: More doctors adopting EHRs to improve patient care and safety

Physician adoption of electronic health record (EHR) and other computerized tools to help improve care, safety and coordination of health care for patients across the county continue to rise, the Office of the National Coordinator for Health Information Technology (ONC) reports in a new data brief. Last week, the Centers for Disease Control and Prevention’s National Center for Health Statistics (NCHS) reported that the percentage of doctors adopting electronic health records has increased from 48 percent in 2009 to 72 percent in 2012. The ONC report shows that since 2009, the percent of physicians with computerized capabilities to e-prescribe has more than doubled, from 33 percent to 73 percent. Within the past year, more physicians (56 percent) have the computerized capabilities to engage with patients and their families by providing patients with summaries after visits, an increase of 46 percent.

To access the full article:

December 19, 2012: HHS announces new investment in school-based health centers

Today Health and Human Services (HHS) Secretary Kathleen Sebelius announced awards of more than $80 million to 197 school-based health center programs across the country, made possible by the Affordable Care Act. This funding will allow school-based health centers to serve an additional 384,000 students, and continue the expansion of preventive and primary health care services. “These new investments will help school-based health centers establish new sites or upgrade their current facilities to keep our children healthy,” said Secretary Sebelius.

To access the full article:

December 20, 2012: States move forward to implement health care law, build health insurance marketplaces

Health and Human Services (HHS) Secretary Kathleen Sebelius today announced that three more states are on track to implement the health care law and establish health insurance marketplaces, or Exchanges, in their states. HHS issued the first conditional approval of a State Partnership Exchange in Delaware and Minnesota and Rhode Island are conditionally approved today to operate a State-based Exchange.
Today’s conditional approvals follow those issued last week to Colorado, Connecticut, the District of Columbia, Kentucky, Massachusetts, Maryland, New York, Oregon, and Washington to operate State-based Exchanges.

To access the full article:

December 26, 2012: FDA approves new orphan drug for rare cholesterol disorder

On Dec. 21, the U.S. Food and Drug Administration approved Juxtapid (lomitapide) to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol, apolipoprotein B, and non-high-density lipoprotein (non-HDL) cholesterol in patients with homozygous familial hypercholesterolemia (HoFH). Juxtapid is intended for use in combination with a low fat diet and other lipid-lowering treatments.
HoFH is a rare inherited condition that makes the body unable to remove LDL cholesterol, often called the “bad” cholesterol, from the blood, causing abnormally high levels of circulating LDL cholesterol. In the United States, HoFH occurs in approximately one in one million individuals. For those with HoFH, heart attacks and death often occur before age 30. Juxtapid works by impairing the creation of the lipid particles that ultimately give rise to LDL.

December 26, 2012: Benefits of higher oxygen, breathing device persist after infancy

By the time they reached toddlerhood, very preterm infants originally treated with higher oxygen levels continued to show benefits when compared to a group treated with lower oxygen levels, according to a follow-up study by a research network of the National Institutes of Health that confirms earlier network findings. Moreover, infants treated with a respiratory therapy commonly prescribed for adults with obstructive sleep apnea fared as well as those who received the traditional therapy for infant respiratory difficulties, the new study found.

To access the full article:

December 31, 2012: FDA approves first drug to treat multi-drug resistant tuberculosis

On Dec. 28, the U.S. Food and Drug Administration approved Sirturo (bedaquiline) as part of combination therapy to treat adults with multi-drug resistant pulmonary tuberculosis (TB) when other alternatives are not available.
TB is an infection caused by Mycobacterium tuberculosis and is one of the world’s deadliest diseases. It is spread from person to person through the air and usually affects the lungs, but it can also affect other parts of the body such as the brain and kidneys. According to the Centers for Disease Control and Prevention, nearly 9 million people around the world and 10,528 people in the United States became sick with TB in 2011.

To access the full article:



December 4, 2012: Improving chemotherapy effectiveness by acting on the immune system

Chemotherapy is one of the most frequently used treatments to eliminate cancerous cells. These drugs kill all cells that are multiplying, or block their proliferation (for example, cells responsible for hair growth, explaining the hair loss of treated patients). In addition to their direct toxic effects, the chemotherapeutic agents also seem to act on the immune system and could make it possible for the body to trigger a direct antitumor immune response in a second phase. However, this last point is still the subject of hot debate, since some studies suggest, conversely, that chemotherapy eliminates all immune defences.

To access the full article:

December 7, 2012: The CEA ranked among the world’s 100 most innovative organizations

The ranking is based on four main evaluation criteria: the overall volume of patents owned by a company or organization, the percentage of patents approved compared to the number of patents filed, the geographic reach of the portfolios held and patent recognition, expressed by the number of citations. For the CEA, which last year filed 665 patents (of which 545 were published) and which is ranked third in France according to the French National Institute for Industrial Property (INPI), its confirmed presence in the ranking of the world’s top 100 most innovative organizations constitutes factual and objective recognition of the efforts made to develop innovation for the purpose of ensuring technology transfer to industry.

To access the full article:

December 12, 2012: The solar roller shutter that runs on all facades and in all seasons

The motorized roller shutter, which can be as large as 2.5 by 3 metres, recovers the solar energy needed to operate it under harsh, exposed weather conditions (facing full north, for example), thanks to a photovoltaic module installed on the casing and specifically developed for the application. The energy is stored in a battery to provide the electrical power required by the motor and ensure that the product is operational, even after several weeks with no sunshine. The CEA-Liten teams have taken particular care over how this battery is controlled, in order to maximize its useful life under the climatic conditions encountered in France. The record service life obtained for an electrochemical component integrated into this consumer product required almost two years of work and gives BUBENDORFF a definite competitive edge.

To access the full article:

December 18, 2012: The role of the innate immune cells in the development of Type 1 diabetes

Type 1 diabetes, or insulin-dependent diabetes, is an auto-immune disease characterised by the destruction of insulin-producing pancreatic β cells that are present in the Islets of Langerhans which are themselves in the pancreas. The peculiarity of this type of diabetes lies in the fact that the cells are destroyed by T lymphocytes that kill the patient’s immune system. This is an auto-immune reaction. Much of the research has highlighted the role of auto-reactive T lymphocytes in the pancreatic β cells. Yet the mechanisms involved in the initial activation of the immune system that triggers the sequence of events leading to the death of the cells are still ill-defined.

To access the full article:

December 19, 2012: Seasons shift on Titan

Earth’s seasons are well understood and are the result of the inclination of the planet’s axis of rotation. The North Pole points towards the Sun in the northern hemisphere summer and therefore receives more light and heat, while in winter it points away from the Sun.
Earth’s tilt is also the reason for the atmospheric circulation in the Tropics, a phenomenon that goes by the name of Hadley cells. The Sun is virtually at its zenith all year round in tropical regions, warming moist upwelling air that drives storms. When it reaches the tropopause, this air stops rising and is forced poleward by the constant flow of rising air from beneath. As it gets further from the equator, the air cools, sinks and then warms again as the prevailing winds push it back towards the equator, where the cycle starts all over again.

To access the full article:

December 19, 2012: Auto-immune disease : the viral route is confirmed

Why would our immune system turn against our own cells? This is the question that the combined Inserm/CNRS/ Pierre and Marie Curie University/Association Institut de Myologie have strived to answer in their “Therapies for diseases of striated muscle”, concentrating in particular on the auto-immune disease known as myasthenia gravis. Through the project known as FIGHT-MG (Fight Myasthenia Gravis), financed by the European Commission and coordinated by Inserm, Sonia Berrih-Aknin and Rozen Le Panse have contributed proof of the concept that a molecule imitating a virus may trigger an inappropriate immune response, causing muscular function to deteriorate. These results have been published in Annals of Neurology, accessible on line.

To access the full article:





High Energy Physics Seminar
January 7, 2013, 4:00 pm
469 Lauritsen
Featured speakers: Doug Beck (University of Illinois)
For further information, please contact Carol Silberstein carol@theory.caltech.edu

General Biology Seminar
January 8, 2013, 4:00 pm
119 Kerckoff
Featured speaker: Thomas Clandinin (Stanford University)
For further information, please contact Julia Boucher jboucher@caltech.edu


The von Kármán Lecture Series: 2013
UAVSAR: An Airborne Window on Earth Surface Deformation
January 20 & 21, 2013
Featured speaker: Scott Hensley (JPL)


Mitochondrial homeostasis and the regulation of metabolism and longevity
January 31, 2013, 4:00 pm
Featured speaker: Johan Auwerx (Laboratory of Integrative and Systems Physiology, Lausanne, Switzerland)


In the Light of Evolution VII: The Human Mental Machinery.
National Academy of Sciences
January 11, 2013, 7:30 am – 8:00 pm
Beckman Center
Featured Speakers: James L. McGaugh (UCI)
For further information, please contact smarty@nas.edu


Personalized Medicine and Cancer Treatements
January 15, 7:00 pm
Ronald Reagan UCLA Medical Center (RRMC) Auditorium, B Level, Room B130
Featured speakers: F. Charles Brunicardi, M.D.


Fourth Annual Nathan J. Zvaifler Rheumatology Lecture
RAIS Special Lecture
January 29, 2013, 12:00 pm
Medical Education and Telemedicine Building conf. room 141
For further information, please contact da Silva Marcia, raidivision@ucsd.edu


Breast Cancer Treatment in the Genomic Era
January 17, 2013 : 4:30pm to 7:00pm
Indian Wells Country Club Wellness Center
Featured speakers: Stephen F. Sener, M.D. (USC), Christy Russell, M.D (USC)
For further information, please contact erinwill@usc.edu


Please consult Le Fil de Marianne for further information on international calls and job offers.


Les bulletins électroniques
Les articles et les rapports produits par les activités de veille scientifique menées par les Missions Scientifiques et Technologiques dans 40 zones géographiques sont accessibles gratuitement via les Bulletins Electroniques. Ils sont édités par l’Agence pour la Diffusion de l’Information Technologique (ADIT), sur une base mensuelle ou hebdomadaire.

Le Fil de Marianne
Le Fil de Marianne est une publication hebdomadaire des bureaux de l’INSERM et du CNRS aux Etats-Unis. Il offre une information détaillée sur les évolutions de la politique de recherche française, les appels d’offres et les manifestations scientifiques en France. L’abonnement est gratuit.

Le Service pour la Science et la Technologie du Consulat Général de France à Los Angeles
Des informations sur le rôle de notre service au sein de la Mission pour la Science et la technologie (MS&T) peuvent être trouvées sur le site du Consulat Général de France à Los Angeles. Le planning des événements à venir ainsi que nos coordonnées et nos activités, sont également disponibles en ligne.


The Office for Science and Technology of the Consulate General of France in Los Angeles
Information about the OST LA’s missions and activities can be found here.


We value your feedback. Please send us your comments and suggestions at deputy-sdv.la@ambascience-usa.org.

Please also check the following websites and newsletters for more information on the activities of the Consulate General of France in Los Angeles:


Subscribe to the monthly French arts and culture newsletter to receive information about shows, exhibitions and much more, by sending an email to : culture@consulfrance-losangeles.org


Subscribe to the monthly French Film and TV newsletter to receive information about projections and events, by sending an email to : frenchfilminla@consulfrance-losangeles.org